UF News

AGTC-501 Gene Therapy Offers Vision Gains for X-Linked RP

AGTC-501 (Applied Genetic Technologies Corporation), a novel gene therapy in development for the potential treatment of X-linked retinitis pigmentosa (RP), showed an acceptable safety profile and visual function improvements when administered in the study’s higher dose groups, according to Robert A. Sisk, MD, FACS, from the Cincinnati Eye Institute in Ohio.

UF Health Team Receives $6.6 Million To Study Treatments To Boost Cognition for Those With HIV

With the support of a $6.6 million program project grant from the National Institute on Alcohol Abuse and Alcoholism, University of Florida researchers, along with colleagues at the University of Miami, Florida State University and the University of Louisville, will evaluate three promising interventions that may improve cognitive function in those with HIV who consume alcohol.

Entrinsic Bioscience Demonstrates Breakthrough GI Barrier Benefits

Entrinsic Bioscience, a pioneering life sciences company incubating at UF Innovate | Accelerate at Sid Martin Biotech, announced results from a new clinical study at renowned Monash University, in Melbourne, Australia. Entrinsic has successfully demonstrated the efficacy of two UF patent-protected formulas, utilizing precise combinations of amino acids, which enabled them to provide targeted gastrointestinal (GI) health and wellness benefits.

Want our news in your inbox every Monday morning? You can!

Subscribe Here